JSA Advocates & Solicitors (JSA) advised Zota Health Care Limited on its Qualified Institutions Placement (“QIP“) aggregating to approximately INR 350 crores. Zota is the leading player in the generic pharmacy space, with its brand of Davaindia stores across India. ICICl Securities Limited acted as the BRLM to the QIP.
The Capital Markets practice of JSA advised on the transaction. The transaction involved sale of 22,80,130 equity shares of face value of INR 10 each, for an aggregate value of approximately INR 350 crores.
The JSA Capital Markets Team was led by Partner Arka Mookerjee, with support from Pracheta Bhattacharya, Partner; Kairav Parikh, Principal Associate; Vatsla Varandani, Senior Associate; Sourav Jena, Associate and Ishika Jain, Associate.
Arka’s practice area involves equity capital markets issuances which covers a wide range of products, such as Initial Public Offerings, Rights Issues, Qualified Institutions Placements, Initial Public Offering of Infrastructure Trusts and foreign currency convertible bonds.